[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100546154":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":35,"locations":41,"responsibleParty":166,"collaborators":11,"id":168,"slug":11,"hasResults":169,"nctId":170,"briefTitle":171,"officialTitle":172,"acronym":11,"eligibilityCriteria":173,"healthyVolunteers":169,"sex":174,"minAge":175,"maxAge":11,"enrollmentInfo":176,"targetDuration":11,"studyType":179,"phases":180,"briefSummary":182,"conditions":183,"keywords":11,"overallStatus":44,"whyStopped":11,"lastUpdateSubmitDate":185,"lastUpdatePostDateStruct":186,"startDateStruct":189,"completionDateStruct":191,"leadSponsor":193,"locationsCount":194},{"fullName":5,"class":6},"Canadian Cancer Trials Group","NETWORK",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard Conventional Radiotherapy","ACTIVE_COMPARATOR",null,[13],"Radiation: Standard Conventional Radiotherapy",{"label":15,"type":16,"description":11,"interventionNames":17},"Stereotactic Body Radiotherapy","EXPERIMENTAL",[18],"Radiation: Stereotactic Body Radiotherapy",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":11},"RADIATION","20Gy in 5 fractions",[9],{"type":21,"name":15,"description":25,"armGroupLabels":26,"otherNames":11},"30 or 35Gy in 5 fractions",[15],[28,32],{"name":29,"affiliation":30,"role":31},"Arjun Sahgal","Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada","STUDY_CHAIR",{"name":33,"affiliation":34,"role":31},"Tim Nguyen","London Regional Cancer Program, London, ON, Canada",[36],{"name":37,"role":38,"phone":39,"phoneExt":11,"email":40},"Wendy Parulekar","CONTACT","613-533-6430","wparulekar@ctg.queensu.ca",[42,61,77,89,102,116,129,139,153],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"BCCA - Vancouver","RECRUITING","Vancouver","British Columbia","V5Z 4E6","Canada","CA",{"type":51,"coordinates":52},"Point",[53,54],-123.11934,49.24966,{"lat":54,"lon":53},[57],{"name":58,"role":38,"phone":59,"phoneExt":60,"email":11},"Emma Dunne","604 877-6000","672773",{"facility":62,"status":63,"city":64,"state":65,"zip":66,"country":48,"countryCode":49,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"Juravinski Cancer Centre at Hamilton Health Sciences","NOT_YET_RECRUITING","Hamilton","Ontario","L8V 5C2",{"type":51,"coordinates":68},[69,70],-79.84963,43.25011,{"lat":70,"lon":69},[73],{"name":74,"role":38,"phone":75,"phoneExt":76,"email":11},"Anand Swaminath","905 387-9495","64706",{"facility":78,"status":44,"city":79,"state":65,"zip":80,"country":48,"countryCode":49,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Kingston Health Sciences Centre","Kingston","K7L 2V7",{"type":51,"coordinates":82},[83,84],-76.48098,44.22976,{"lat":84,"lon":83},[87],{"name":88,"role":38,"phone":11,"phoneExt":11,"email":11},"Michael Kucharczyk",{"facility":90,"status":44,"city":91,"state":65,"zip":92,"country":48,"countryCode":49,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"London Health Sciences Centre Research Inc.","London","N6A 5W9",{"type":51,"coordinates":94},[95,96],-81.23304,42.98339,{"lat":96,"lon":95},[99],{"name":100,"role":38,"phone":101,"phoneExt":11,"email":11},"Timothy Nguyen","519 685-8600",{"facility":103,"status":44,"city":104,"state":65,"zip":105,"country":48,"countryCode":49,"cosmosGeoPoint":106,"geoPoint":110,"contacts":111},"Stronach Regional Health Centre at Southlake","Newmarket","L3Y 2P9",{"type":51,"coordinates":107},[108,109],-79.46631,44.05011,{"lat":109,"lon":108},[112],{"name":113,"role":38,"phone":114,"phoneExt":115,"email":11},"Zahra Kassam","905 895-4521","6595",{"facility":117,"status":44,"city":118,"state":65,"zip":119,"country":48,"countryCode":49,"cosmosGeoPoint":120,"geoPoint":124,"contacts":125},"Odette Cancer Centre","Toronto","M4N 3M5",{"type":51,"coordinates":121},[122,123],-79.39864,43.70643,{"lat":123,"lon":122},[126],{"name":127,"role":38,"phone":128,"phoneExt":11,"email":11},"Alexander Louie","416 480-4951",{"facility":130,"status":44,"city":118,"state":65,"zip":131,"country":48,"countryCode":49,"cosmosGeoPoint":132,"geoPoint":134,"contacts":135},"University Health Network","M5G 2M9",{"type":51,"coordinates":133},[122,123],{"lat":123,"lon":122},[136],{"name":137,"role":38,"phone":138,"phoneExt":11,"email":11},"Chiaojung Jillian Tsai","416 946-4501",{"facility":140,"status":44,"city":141,"state":142,"zip":143,"country":48,"countryCode":49,"cosmosGeoPoint":144,"geoPoint":148,"contacts":149},"CHUM-Centre Hospitalier de l'Universite de Montreal","Montreal","Quebec","H2X 3E4",{"type":51,"coordinates":145},[146,147],-73.58781,45.50884,{"lat":147,"lon":146},[150],{"name":151,"role":38,"phone":152,"phoneExt":11,"email":11},"Giuseppina Laura Masucci","514 890-8254",{"facility":154,"status":44,"city":155,"state":142,"zip":156,"country":48,"countryCode":49,"cosmosGeoPoint":157,"geoPoint":161,"contacts":162},"Hotel-Dieu de Quebec","Québec","G1R 2J6",{"type":51,"coordinates":158},[159,160],-71.21454,46.81228,{"lat":160,"lon":159},[163],{"name":164,"role":38,"phone":165,"phoneExt":11,"email":11},"Isabelle Thibault","418 691-5181",{"type":167,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100546154",false,"NCT06391242","Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases","A Randomized Phase III Trial Comparing Stereotactic Body Radiotherapy to Conventional Palliative Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Participants With Painful Non-Spine Bone Metastases","Inclusion Criteria:\n\n* Histologic confirmation of solid tumour.\n* Patient with a dominant painful non-spine bone metastasis and a worst minimum pain score of 2 using the BPI attributed to that dominant site\n* Expected overall survival of greater than 6 months as determined by the treating physician\n* Suitable for protocol defined SBRT and CRT.\n* Stable pain with no immediate plan to alter analgesic regimen.\n* ECOG performance status of 0-2.\n* Participant consent must be appropriately obtained in accordance with applicable local and regulatory requirements. Each participant must sign a consent form prior to enrolment in the trial to document their willingness to participate\n\nExclusion Criteria:\n\n* Metastases of the hands, feet, cranium or spine (including sacrum) as the dominant\u002Findex pain site.\n* Bone metastasis arising from a small cell or germ cell.\n* Radionuclide therapy within 30 days of randomization.\n* Patient treated with prior palliative RT to the dominant painful bone metastasis site (prior radiation exposure is permitted if prior to development of the dominant metastasis and would not influence the applicability of either treatment arm of the current study).\n* Received systemic chemotherapy within 1 week of the protocol RT, or who are expected\u002Fplanned to receive chemotherapy within one week of completing protocol RT.\n* Participants with an unstable pathologic fracture at the dominant painful bone metastasis, or for whom surgical fixation would be the preferred intervention if possible.\n* Pregnant or lactating individuals.","ALL","18 Years",{"count":177,"type":178},230,"ESTIMATED","INTERVENTIONAL",[181],"PHASE3","This study is being done to answer the following question: Is Stereotactic Body Radiation Therapy or SBRT (a form of radiation therapy which can deliver high doses of radiation to the specific painful area of the body most affected by cancer, while keeping the radiation beams away from the healthy parts of the body that surround the cancer) better for pain relief than the standard treatment of conventional radiation therapy or CRT (a form of radiation therapy which delivers radiation to the painful area but can also negatively affect other parts of the body in the same area)",[184],"Cancer Metastatic","2026-06-08",{"date":187,"type":188},"2026-06-09","ACTUAL",{"date":190,"type":188},"2025-03-07",{"date":192,"type":178},"2028-01-01",{"name":5,"class":6},9]